Venture capital firm based in Oxford, UK
CryoLogyx secures £500k in funding to revolutionize cryopreserved cell technology and expand market presence in UK and Europe. Read more
Revolutionizing cancer detection, Oxford Cancer Analytics secures $5.5 million to unleash groundbreaking blood tests that could catch lethal cancers before they strike. Read more
| Healthtech | 66.7% |
| Biotech | 33.3% |